Patents by Inventor Geoff G. Z. Zhang

Geoff G. Z. Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7498444
    Abstract: The present invention relates to the salt (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate and to methods of preparing the salt.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: March 3, 2009
    Assignee: Abboott Laboratories
    Inventors: Gregory S. Wayne, Sean M. Mellican, Geoff G. Z. Zhang, David R. Willcox, Jeffrey M. Breting
  • Patent number: 7449584
    Abstract: N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide Crystalline Form 1, ways to make it, compositions containing it and methods of treatment of diseases using it are disclosed.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: November 11, 2008
    Assignee: Abbott Laboratories Inc.
    Inventors: Eric A. Schmitt, Ira S. Buckner, Geoff G. Z. Zhang, Rodger F. Henry
  • Patent number: 7446206
    Abstract: N-((2Z)-2-((4-Hydroxyphenyl)imino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide Crystalline Form 2, ways to make it, compositions containing it and methods of treatment of diseases using it are disclosed.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: November 4, 2008
    Assignee: Abbott Laboratories Inc.
    Inventors: Eric A. Schmitt, Ira S. Buckner, Geoff G. Z. Zhang, Rodger F. Henry
  • Patent number: 7354937
    Abstract: The present invention discloses (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane, salts thereof, and its use to treat pain and other disorders associated with the nicotinic acetylcholine receptor.
    Type: Grant
    Filed: July 7, 2005
    Date of Patent: April 8, 2008
    Assignee: Abbott Laboratories
    Inventors: Michael J. Buckley, Jianguo Ji, Geoff G. Z. Zhang, Rodger F. Henry, Weili W. Wang, Gregory S. Wayne, Wenke Li, Timothy B. Towne, Steven J. Wittenberger, Steven M. Hannick, Brian J. Kotecki, Bryan S. Macri, Timothy A. Robbins
  • Patent number: 7351833
    Abstract: The present invention relates to the salt (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate and to methods of preparing the salt.
    Type: Grant
    Filed: July 7, 2005
    Date of Patent: April 1, 2008
    Assignee: Abbott Laboratories
    Inventors: Gregory S. Wayne, Sean M. Mellican, Geoff G. Z. Zhang, David R. Willcox, Jeffrey M. Breting
  • Patent number: 7259186
    Abstract: In one aspect, the present invention relates to a formulation in the form of molecular dispersion comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients. In a second aspect, the present invention relates to novel salts of fenofibric acid that are photostable when compared to other salts of fenofibric acid.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: August 21, 2007
    Assignee: Abbott Laboratories
    Inventors: Russell Drew Cink, Joseph B. Paterson, Jr., Yi Gao, Geoff G. Z. Zhang, Michelle A. Long, John B. Morris, Joerg Rosenberg